2023 NICE 技术鉴定指导意见：纳武单抗联合氟嘧啶类和铂类化疗治疗未经治疗的不可切除的晚期、复发性或转移性食管鳞状细胞癌【TA865】.pdfVIP

Nivolumabwith

fluoropyrimidine-and

platinum-based

chemotherapyfor

untreatedunresectable

advanced,recurrent,or

metastaticoesophageal

squamouscellcarcinoma

Technologyappraisalguidance

Published:8February2023

.uk/guidance/ta865

©NICE2023.Allrightsreserved.SubjecttoNoticeofrights(.uk/terms-and-

conditions#notice-of-rights).

Nivolumabwithfluoropyrimidine-andplatinum-basedchemotherapyforuntreated

unresectableadvanced,recurrent,ormetastaticoesophagealsquamouscellcarcinoma

(TA865)

Yourresponsibility

Therecommendationsinthisguidanc